STADA Acquires Walmark from MidEuropa
November 4, 2019
STADA Arzneimittel AG has agreed to acquire Walmark a.s., a leading consumer healthcare company in Central Europe, from private equity firm MidEuropa Partners. The deal (consideration undisclosed) expands STADA's branded consumer health portfolio and strengthens its presence across Central and Eastern Europe; the transaction was expected to close in Q1 2020 subject to antitrust clearance.
- Buyers
- STADA Arzneimittel AG
- Targets
- Walmark a.s.
- Sellers
- MidEuropa Partners
- Industry
- Consumer Products
- Location
- Czech Republic
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CapVest Acquires Majority Stake in STADA Arzneimittel
September 1, 2025
Healthcare Services
CapVest Partners LLP has completed its acquisition of a majority stake in STADA Arzneimittel AG, a global healthcare and pharmaceuticals company focused on consumer healthcare, generics, and specialty pharmaceuticals. CapVest and STADA plan to accelerate STADA’s global growth through both organic initiatives and strategic acquisitions.
-
STOK Acquires BEWI's Packaging Trading Business (BEWI Food)
October 30, 2024
Packaging
STOK, a portfolio company of A&M Capital Europe (AMCE), has entered into a binding agreement to acquire BEWI's trading business ("BEWI Food"), a leading distributor of food packaging in Norway and Iceland. The deal is STOK's first add-on since AMCE's April 2024 investment and is intended to create a leading packaging distributor across Denmark, Norway, Iceland and Greenland, with combined pro forma sales of ~€190m in 2024.
-
Astorg Acquires Majority Stake in Steliau
February 26, 2024
Industrial Services
Astorg, a European private equity firm, has signed an agreement to acquire a majority stake in Steliau, a pan-European value-added distributor (VAD) of electronic solutions, from B&Capital. Steliau, founded in 1992 and headquartered in Montrouge, France, employs more than 200 people across eight countries and will partner with Astorg to accelerate organic growth and execute a buy-and-build strategy.
-
MidEuropa Acquires Majority Stake in Optegra Eye Health Care
February 22, 2023
Healthcare Services
MidEuropa has completed the acquisition of a majority stake in Optegra Eye Health Care from H2 Equity Partners, with H2 and Optegra management reinvesting alongside MidEuropa. Optegra is a multi‑national ophthalmology platform operating 29 specialist facilities across the UK, Poland, Czech Republic and Slovakia and performs over 100,000 surgical procedures per year; MidEuropa intends to accelerate the company’s geographic expansion and growth across Europe.
-
STADA Acquires Biopharma's Pharmaceutical Prescription and Consumer Health Business
December 12, 2019
Pharmaceuticals
The STADA Group agreed to acquire the pharmaceutical prescription and consumer health business of Ukrainian producer Biopharma, including GMP-certified production facilities in Bila Tserkva. The deal integrates Biopharma's pharma operations into STADA's European organization, expands STADA's local production footprint in Ukraine and is subject to Ukrainian merger control; Biopharma's shareholders will retain the company's plasma business.
-
Equistone Partners Europe Acquires Majority Stake in Omnicare
August 14, 2019
Pharmaceuticals
Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.